IQVIA

Yahoo Finance • 11 hours ago

Oracle initiated, Roblox upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: MoffettNathanson upgraded Roblox (RBLX... Full story

Yahoo Finance • 5 days ago

Could IQVIA’s (IQV) Expanded Vaccine Analytics Signal a New Phase in Its Healthcare Partnerships?

On October 2, 2025, GSK and IQVIA announced a major update to their Vaccine Track data tool, expanding local-level coverage to 387 U.S. metro areas and providing a full decade of adult immunization insights. This collaboration enhances the... Full story

Yahoo Finance • 7 days ago

INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag

[Sector index data, health care, industrials, insurance.] Torsten Asmus/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]), which tracks the health care sector, and... Full story

Yahoo Finance • 8 days ago

Why IQVIA (IQV) Stock Is Trading Up Today

What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 6.3% in the afternoon session after the company, in partnership with GSK, announced a major update to its Vaccine Track data tool for tracking adult immunization... Full story

Yahoo Finance • 13 days ago

Amneal seeks FDA nod for generic targeting Xolair marketed by Roche and Novartis

[US Food and Drug Administration (FDA)] * Amneal Pharmaceuticals (NASDAQ:AMRX [https://seekingalpha.com/symbol/AMRX]) on Friday announced the FDA submissions to seek U.S. approval for an off-patent version of Xolair, an asthma therapy m... Full story

Yahoo Finance • 14 days ago

IQVIA Holdings (IQV) Shares Cross Below 200 DMA

In trading on Friday, shares of IQVIA Holdings Inc (Symbol: IQV) crossed below their 200 day moving average of $248.31, changing hands as low as $247.32 per share. IQVIA Holdings Inc shares are currently trading down about 1.9% on the day... Full story

Yahoo Finance • 30 days ago

IQV Quantitative Stock Analysis

Below is Validea's guru fundamental report for IQVIA HOLDINGS INC (IQV). Of the 22 guru strategies we follow, IQV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model look... Full story

Yahoo Finance • last month

Can IQVIA Holdings Inc.'s (NYSE:IQV) ROE Continue To Surpass The Industry Average?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine IQVIA Holdings Inc. (NYSE:IQV),... Full story

Yahoo Finance • last month

IQVIA partners with Flagship Pioneering to boost biotech development

* IQVIA (NYSE:IQV [https://seekingalpha.com/symbol/IQV]) on Thursday said in a statement that it would collaborate with Flagship Pioneering to accelerate the development of breakthrough life sciences companies. * The deal would give Fl... Full story

Yahoo Finance • last month

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the biop... Full story

Yahoo Finance • last month

IQVIA Holdings Inc. (IQV): A Bull Case Theory

We came across a bullish thesis on IQVIA Holdings Inc. on Rebound Capital’s Substack. In this article, we will summarize the bulls’ thesis on IQV. IQVIA Holdings Inc.'s share was trading at $191.15 as of August 22nd. IQV’s trailing and for... Full story

Yahoo Finance • 2 months ago

Can AI make clinical trials better?

Investing.com -- Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number of novel drug approvals... Full story

Yahoo Finance • 2 months ago

What's going on in today's session: S&P500 movers

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT PKG [https://www.chartmill.com/s... Full story

Yahoo Finance • 2 months ago

David Tepper's Strategic Moves: UnitedHealth Group Inc. Takes Center Stage with 11% Portfolio Impact

Exploring Tepper's Investment Shifts in Q2 2025 David Tepper (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. David Alan Tepper is the f... Full story

Yahoo Finance • 2 months ago

IQVIA’s SWOT analysis: healthcare analytics leader faces market headwinds

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, continues to navigate a complex market environment. With a market... Full story

Yahoo Finance • 2 months ago

Guru Fundamental Report for IQV

Below is Validea's guru fundamental report for IQVIA HOLDINGS INC (IQV). Of the 22 guru strategies we follow, IQV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model look... Full story

Yahoo Finance • 2 months ago

Hospital Information Systems Company Evaluation Report 2025 | Epic Systems, AdvancedMD, and Dedalus Lead with Integrated EHR, Practice Management, and Digital Transformation Solutions

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Hospital Information Systems Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The Hospital Information System Companies Quadrant is a comprehensive industr... Full story

Yahoo Finance • 2 months ago

Viatris wins FDA nod for generic iron sucrose injection targeting Daiichi’s Venofer

[FDA headquarters in Washington DC.] JHVEPhoto Viatris (NASDAQ:VTRS [https://seekingalpha.com/symbol/VTRS]) announced on Monday that the U.S. FDA has approved its Iron Sucrose Injection, USP, as a generic product targeting Venofer markete... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: Pfizer, UnitedHealth, Sarepta and Thermo Fisher in focus

Wall Street ended higher on Friday, capping off a strong week that saw both the Nasdaq Composite and S&P 500 finish the week at fresh record highs. For the week the Dow (DJI [https://seekingalpha.com/symbol/DJI]) rose 1.2%, the S&P 500 (S... Full story

Yahoo Finance • 3 months ago

Stock Index Futures Climb as U.S. Reaches Trade Deal With Japan, Tesla and Alphabet Earnings Awaited

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are up +0.39%, and September Nasdaq 100 E-Mini futures (NQU25 [https://www.barchart.com/futures/quotes/NQU25/overview]) are up +0.19% this morning as... Full story